What Foamix Pharmaceuticals Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Schwartz Aharon | Director | Mar 09 | Disposition to Issuer · D | −112,200 | — | — | 0 |
| Hadar Ilan | CFO & Country Manager | Mar 09 | Disposition to Issuer · D | −116,501 | — | — | 0 |
| Hadar Ilan | CFO & Country Manager | Mar 09 | Disposition to Issuer · D | −14,077 | — | — | 116,501 |
| Domzalski David | CEO | Mar 09 | Disposition to Issuer · D | −233,126 | — | — | 0 |
| Domzalski David | CEO | Mar 09 | Disposition to Issuer · D | −90,902 | — | — | 233,126 |
| Harsch Mutya | CLO and General Counsel | Mar 09 | Disposition to Issuer · D | −85,490 | — | — | 0 |
| Harsch Mutya | CLO and General Counsel | Mar 09 | Disposition to Issuer · D | −12,742 | — | — | 85,490 |
| Stuart Iain | Chief Scientific Officer | Mar 09 | Disposition to Issuer · D | −91,303 | — | — | 0 |
| Stuart Iain | Chief Scientific Officer | Mar 09 | Disposition to Issuer · D | −12,333 | — | — | 91,303 |
| Wiley Matthew T. | Chief Commercial Officer | Mar 09 | Disposition to Issuer · D | −78,799 | — | — | 0 |
| Wiley Matthew T. | Chief Commercial Officer | Mar 09 | Disposition to Issuer · D | −35,275 | — | — | 78,799 |
| Stern Stanley | Director | Mar 09 | Disposition to Issuer · D | −21,212 | — | — | 0 |
| Stern Stanley | Director | Mar 09 | Disposition to Issuer · D | −21,147 | — | — | 21,212 |
| Bruno Anthony D | Director | Mar 09 | Disposition to Issuer · D | −12,360 | — | — | 0 |
| Bruno Anthony D | Director | Mar 09 | Disposition to Issuer · D | −62,647 | — | — | 12,360 |
| Hirsch Stanley | Director | Mar 09 | Disposition to Issuer · D | −59,016 | — | — | 0 |
| Hirsch Stanley | Director | Mar 09 | Disposition to Issuer · D | −182,500 | — | — | 59,016 |
| Hirsch Stanley | Director | Mar 09 | Disposition to Issuer · D | −52,842 | — | — | 241,516 |
| Kazanchyan Anna | Director | Mar 09 | Disposition to Issuer · D | −43,030 | — | — | 0 |
| Kazanchyan Anna | Director | Mar 09 | Disposition to Issuer · D | −15,714 | — | — | 43,030 |
Loading...